´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(3ÀÏÂ÷) : 2021-10-02±³À°ÀÏÀÚ : 2021-10-02
±³À°Àå¼Ò : ½Ç½Ã°£ È»ó°ÀÇ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)LMCE 2021 & KSLM 62Â÷ Ãß°èÇмú´ëȸ(3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ
´ã´çÀÚ : ±èÈñ¼ø
¿¬¶ôó : 02-795-9914
À̸ÞÀÏ :
kscp3@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 10 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Á¤È¸¿ø 10¸¸¿ø/ÁØȸ¿ø Àü°øÀÇ,º´¸®»ç 8¸¸¿ø/ºñȸ¿ø 25¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-02 CHANNEL1 09:00~09:30 What is the preferred marker of Cardiac Myocyte injury or death in 2021? William E. Winter(University of Florida Gainsville USA)
±³À°½Ã°£ 10-02 CHANNEL1 09:30~10:00 ½ÉºÎÀü Ç¥ÁöÀÚ Yonggeun Cho(Hallym University Sacred Heart Hospital Korea)
±³À°½Ã°£ 10-02 CHANNEL1 10:00~10:30 ½ÉÇ÷°üÀ§Çèµµ Ç¥ÁöÀÚ Soo Young Moon(Pusan National University School of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL2 09:00~09:20 The role of public agency in strengthening the national capacity for diagnosis of infectious diseases Jae-Sun Park(Korea Disease Control and Prevention Agency Korea)
±³À°½Ã°£ 10-02 CHANNEL2 09:20~09:40 The role of academic society in strengthening the national capacity for diagnosis of infectious diseases Hyukmin Lee(Yonsei University College of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL2 09:40~10:00 National surveillance system for COVID-19 variant Jee Eun Lee(Korea Disease Control and Prevention Agency Korea)
±³À°½Ã°£ 10-02 CHANNEL2 10:00~10:30 National diagnostic system after vaccination Jae-Seok Kim(Hallym University College of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL1 11:00~12:00 Point of care molecular testing David R. Peaper(Yale University School of Medicine USA)
±³À°½Ã°£ 10-02 CHANNEL1 12:00~12:30 Laboratory medicine & healthcare excellence Tricia Ravalico(Abbott)
±³À°½Ã°£ 10-02 CHANNEL1 12:00~12:30 Laboratory medicine & healthcare excellence Colleen Strain(Abbott)
±³À°½Ã°£ 10-02 CHANNEL1 12:40~13:20 How to implement a PBM program at your hospital Mark Yazer(University of Pittsburgh USA)
±³À°½Ã°£ 10-02 CHANNEL1 13:30~14:00 AdvanSure SARS-CoV-2 IgG ELISA for monitoring immune response after infection or vaccination Eun-Jee Oh(The Catholic University of Korea College of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL1 14:00~14:20 CAR-T cell therapy and apheresis support Kyoung Un Park(Seoul National University College of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL1 14:20~14:40 CAR-NK cell therapy and ex vivo expansion of NK cells Duck Cho(Sungkyunkwan University School of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL1 14:40~15:00 GMP for cell therapy and advanced regenerative bio act Jong Wook Chang(Samsung Medical Center & ENCell Co. Ltd Korea)
±³À°½Ã°£ 10-02 CHANNEL1 15:00~15:30 Lentiviral vector for cell and gene therapy Brian (Byoung) Ryu(Umoja Biopharma USA)
±³À°½Ã°£ 10-02 CHANNEL2 14:00~14:20 Regulation plan of manufacturing and distribution of IVD Hongmo Seong(Ministry of Food and Drug Safety Korea)
±³À°½Ã°£ 10-02 CHANNEL2 14:20~14:40 Regulation of post-market surveillance of foreign countries Young-Wook Ahn(Ministry of Food and Drug Safety Korea)
±³À°½Ã°£ 10-02 CHANNEL2 14:40~15:00 Plan of collection and evaluation of IVD Kyoung Ho Roh(National Health Insurance Service Ilsan Hospital Korea)
±³À°½Ã°£ 10-02 CHANNEL2 15:00~15:30 Optimal distribution and storage plan in domestic IVD company Young Kyung Lee(Hallym University Kangdong Sacred Heart Hospital Korea)
±³À°½Ã°£ 10-02 CHANNEL3 14:00~14:20 Quality control in routine hematology Ji-Myung Kim(Chungnam National University College of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL3 14:20~14:40 Quality control in clinical microbiology In Young Yoo(Seoul St. Mary)
±³À°½Ã°£ 10-02 CHANNEL3 14:40~15:00 Quality control in flow cytometry Kyung-Hwa Shin(Pusan National University School of Medicine Korea)
±³À°½Ã°£ 10-02 CHANNEL3 15:00~15:30 Quality control of histocompatibility test Borae G. Park(Korea University Guro Hospital Korea)